Chang Y, Cesarman EC, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDSassociated Kaposi's sarcoma. Science 1994; 266: 1865–1869.
Ambroziak JA, Blackbourn DJ, Herndier BG, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995; 268: 582–583.
Huang YQ, Li JJ, Kaplan MH, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995; 345: 759–761.
Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995; 332: 1181–1185.
Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1995; 1: 707–708.
Chang Y, Ziegler J, Wabinga H, et al. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. Arch Intern Med 1996; 156: 202–204.
Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332: 1186–1191.
Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995; 86: 1276–1280.
Marcelin AG, Dupin N, Bouscary D, et al. HHV8 and multiple myeloma in France. Lancet 1997; 350: 1144.
MacKenzie J, Sheldon J, Morgan G, Cook G, Schulz TF, Jarrett RF. HHV8 and multiple myeloma in UK. Lancet 1997; 350: 1144–1145.
Gao SJ, Alsina M, Deng JH, et al. Antibodies to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in patients with multiple myeloma. J Infect Dis 1998; 178: 846–849.
Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996; 2: 918–924.
Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996; 348: 858–861.
Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 346: 1133–1138.
Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 1995; 346: 799–802.
Moore PS, Kingsley LA, Holmberg SD, et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996; 10: 175–180.
Gao SJ, Kingsley LA, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996; 335: 233–241.
Boshoff C, Schulz TF, Kennedy MM, et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1995; 1: 1274–1278.
Gao SJ, Kingsley LA, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996; 2: 925–928.
International Agency for Research on Cancer. Infections with Epstein-Barr virus and human herpesviruses, Vol. 70, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Lyon, 1997.
Schmid DS. Role of HHV8 in Kaposi Sarcoma. JAMA 1998; 280: 570–571.
Ensoli B, Sturzl M. Kaposi's sarcoma: A results of the interplay among inflammatory cytokines, angiogenic factors and viral agents. In: Sporn M, Vilcek JT (eds), Cytokine and Growth Factor Review, Vol 9, 1998; 63–83.
Rabkin CS, Schulz TF, Whitby D, et al. Interassay correlation of human herpesvirus 8 serologic tests. HHV8 Interlaboratory Collaborative Group. J Infect Dis 1998; 178: 304–309.
Sharp D. Current assays for HHV8 seropositivity unreliable. Lancet 1998; 352: 965.
Kedes DH, Ganem D, Ameli N, Bacchetti P, Greenblatt R. The prevalence of serum antibody to human herpes virus 8 (Kaposi's sarcoma-associated virus) among HIV-seropositive and high-risk HIV-seronegative women. JAMA 1997; 277: 478–481.
Lin JC, Lin SC, Mar EC, et al. Is Kaposi's sarcomaassociated herpesvirus detectable in semen of HIV-infected homosexual men? Lancet 1995; 346: 1601–1602.
Monini P, de Lellis LD, Fabris M, Rigolin F, Cassai E. Kaposi's sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen. N Engl J Med 1996; 334: 1168–1172.
Olsen SJ, Chang Y, Moore PS, Biggar RJ, Melbye M. Increasing Kaposi's sarcoma associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. AIDS 1998; 12: 1921–1925.
Mayama S, Cuevas LE, Sheldon J, et al. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (Human Herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 1998; 77: 817–820.
Andreoni M, El-Sawaf G, Rezza G, et al. High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: Evidence of non-sexual transmission. J Natl Cancer Inst 1999; 91: 465–469.
Gessain A, Mauclere P, van Beveren M, et al. Human herpesvirus 8 primary infection occurs during childood in Cameroon, Central Africa. Int J Cancer 1999 81: 189–192.
Rezza G, Andreoni M, Dorrucci M, et al. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndromerelated diseases. J Natl Cancer Inst 1999; 91: 1468–1474.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective stiudies of disease. J Natl Cancer Inst 1959; 22: 719–748.
Rezza G, Tchangmena OB, Andreoni M, et al. Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. Sexually Transmitted Diseases 2000; 27: 159–164.
Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49: 33–64.
Bestetti G, Renon G, Mauclere P, et al. High seroprevalence of human herpesvirus-8 in pregnant women and prostitutes from Cameroon. AIDS 1998; 12: 541–543.
de-The G, Bestetti G, van Beveren M, Gessain A. Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease-syndrome-related epidemic of Kaposi's sarcoma in East Africa. J Natl Cancer Inst 1999; 91: 1888–1889.
Perna AM, Bonura F, Vitale F, et al. Antibodies to human herpes virus type 8 (HHV8) in general population and in individuals at risk for sexually transmitted diseases in Western Sicily. Int J Epidemiol 2000; 29: 175–179.
Davidovici B, Karakis I, Bourboulia D, et al. Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel. J Natl Cancer Inst 2001; 93: 194–203.
Plancoulaine S, Abel L, van Beveren M, et al. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 2000; 356: 1062–1065.
Geddes M, Franceschi S, Balzi D, Arniani S, Gafa L, Zanetti R. Birthplace and classic Kaposi's sarcoma in Italy. J Natl Cancer Inst 1995; 87: 1015–1017.
Franceschi S, Geddes M. Epidemiology of classic Kaposi's sarcoma, with special reference to Mediterranean population. Tumori 1995; 81: 308–314.
Beral V. Epidemiology of Kaposi's sarcoma. Cancer Surveys 1991; 10: 5–22.
Fife K, Bower M. Recent insights into the pathogenesis of Kaposi's sarcoma. Br J Cancer 1996; 73: 1317–1322.